SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C.  20549

                         ------------------------------

                                    FORM 8-K

                                 CURRENT REPORT


                     PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934


                                  May 21, 1997
                        ---------------------------------
                                 Date of Report
                        (Date of earliest event reported)


                               ALCIDE CORPORATION
- --------------------------------------------------------------------------------
             (Exact name of registrant as specified in its charter)

          Delaware                   0-12395                  22-2445061
- --------------------------    ---------------------      --------------------
      (State or other         (Commission File No.)         (IRS Employer
      jurisdiction of                                     Identification No.)
       incorporation)

                          8561 154th Avenue North East
                               Redmond, WA 98052
- --------------------------------------------------------------------------------
          (Address of principal executive offices, including zip code)

                                 (425) 882-2555
- --------------------------------------------------------------------------------
              (Registrant's telephone number, including area code)


                                                         Exhibit Index on Page 4



ITEM 5.   OTHER EVENTS

     On May 21, 1997, Alcide Corporation (the "Company") and Novus
International, Inc. ("Novus") signed an agreement granting Novus exclusive
worldwide marketing rights to the Company's line of poultry antimicrobial
interventions and an option for distribution rights for future food processing
antimicrobial products.

ITEM 7.   FINANCIAL STATEMENT, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS

Exhibit No.              Description
- -----------              -----------

10.23*                   Agreement, dated May 21, 1997, between the Registrant
                         and Novus International, Inc., a Delaware corporation.



- ---------------------
     * Confidential Treatment has been requested for this exhibit.



                                    SIGNATURE

     Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                   ALCIDE CORPORATION

     Dated:  May 30, 1997

                                   By /s/ John P. Richards
                                      ---------------------------------
                                      John P. Richards
                                      Executive Vice President
                                      and Chief Financial Officer



                                  EXHIBIT INDEX


Exhibit No.         Description
- -----------         -----------

10.23*              Agreement, dated May 21, 1997, between the Registrant and
                    Novus International, Inc., a Delaware corporation.



- --------------------
     * Confidential Treatment has been requested for this exhibit.